QA: Transcode Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001829635_2023_Transcode_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001829635, Transcode Therapeutics Inc.

  xvar xval
0 AssetsCurrent 7,379,405
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 208,581
3 remainder_Assets 0
4 LiabilitiesCurrent 4,347,290
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,433,448
9 ResearchAndDevelopmentExpense 10,232,366
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,100,846
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,587,986
1 Liabilities 4,347,290
2 Expenses 18,665,814
3 Revenues 0
4 StockholdersEquity 3,240,696
5 NetIncome -17,564,968
6 ComprehensiveNetIncome -17,564,968
7 BaseVar 15,850,968
8 EconomicCapitalRatio -2.01

Edgar->Model Mapping

Feature Distribution

Change over Time